Status:
UNKNOWN
Multimodal Ultrasound in Inflammatory Bowel Diseases
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The role of intestinal ultrasound in treatment monitoring has recently gained increasing interest thanks to its non-invasiveness, cost-effectiveness and largely availability. Moreover, new ultrasonogr...
Detailed Description
Background: Clinical remission is no more considered an appropriate therapeutic target for Inflammatory Bowel Diseases (IBD) and other parameters such as endoscopic and transmural remission are now re...
Eligibility Criteria
Inclusion
- written informed consent
- diagnosis of Crohn's disease or Ulcerative Colitis
- indication to start biologic treatment according to international guidelines
- affected intestinal segment detectable in B-mode ultrasound
Exclusion
- induction of biologic therapy in prophylaxis after surgery in Crohn's disease
- lack of visualization of affected intestinal tract (eg. obesity)
- diagnosis of undetermined colitis
- hearth failure
- known allergy to ultrasound contrast agents
- pregnancy
- lactation
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05987501
Start Date
December 1 2019
End Date
December 1 2024
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Gemelli IRCCS
Roma, Italy, 00168